Page 512 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

490 PART IV Specific Malignancies in the Small Animal Patient

581. Pisani G, Millanta F, Lorenzi D, et al.: Androgen receptor expres- 606. Wouda RM, Borrego J, Keuler NS, et al.: Evaluation of adjuvant
sion in normal, hyperplastic and neoplastic hepatoid glands in the carboplatin chemotherapy in the management of surgically excised
dog, Res Vet Sci 81:231–236, 2006. anal sac apocrine gland adenocarcinoma in dogs, Vet Comp Oncol
VetBooks.ir 582. Petterino C, Martini M, Castagnaro M: Immunohistochemical 607. Turek MM, Forrest LJ, Adams WM, et al.: Postoperative radio-
14:67–80, 2016.
detection of growth hormone in canine hepatoid gland tumors,
J Vet Med Sci 66:569–572, 2004.
583. Brodzki A, Tatara MR, Brodzki P: Serum concentrations of magne- therapy and mitoxantrone for anal sac adenocarcinoma in the dog:
15 cases (1991-2001), Vet Comp Oncol 1:94–104, 2003.
sium in dogs suffering from tumors of the perianal glands, Magnes 608. Bowlt KL, Friend EJ, Delisser P, et al.: Temporally separated bilat-
Res 26:87–92, 2013. eral anal sac gland adenocarcinomas in four dogs, J Small Anim
584. Stannard AA, Pulley LT: Tumors of the skin and soft tissues. In Pract 54:432–436, 2013.
Moulton JE, editor: Tumors in domestic animals, ed 2, Berkeley, 609. Meier V, Polton G, Cancedda S, et al.: Outcomes in dogs with
1978, University of California Press, pp 16–70. advanced (stage 3b) anal sac gland carcinoma treated with sur-
585. Ganguly A, Wolfe LG: Canine perianal gland carcinoma-associ- gery or hypofractionated radiation therapy, Vet Comp Oncol 15:
ated antigens defined by monoclonal antibodies, Hybridoma 25: 1073–1086, 2017.
10–14, 2006. 610. Barnes DC, Demetriou JL: Surgical management of primary, meta-
586. Pieper J, Stern A, LeClerc S: Coordinate expression of cytokeratin static and recurrent anal sac adenocarcinoma in the dog: 52 cases,
7 and 14, vimentin and Bcl-2 in canine cutaneous epithelial tumors J Small Anim Pract 58:263–268, 2017.
and cysts, J Vet Diagn Invest 27:497–503, 2015. 611. White RAS, Gorman NT: The clinical diagnosis and management
587. Tozon N, Kodre V, Sersa G, et al.: Effective treatment of perianal of rectal and pararectal tumours in the dog, J Small Anim Pract
tumors in dogs with electrochemotherapy, Anticancer Res 25:839– 28:87–107, 1987.
845, 2005. 612. Hause WR, Stevenson S, Meuten DJ, et al.: Pseudohyperparathy-
588. Liska WD, Withrow SJ: Cryosurgical treatment of perianal gland roidism associated with adenocarcinomas of anal sac origin in four
adenomas in the dog, J Am Anim Hosp Assoc 14:457–463, 1978. dogs, J Am Anim Hosp Assoc 17:373–379, 1981.
589. Shelley BA: Use of the carbon dioxide laser for perianal and rectal 613. Meuten DJ, Segre GV, Capen CC, et al.: Hypercalcemia in dogs
surgery, Vet Clin North Am Small Anim Pract 32:621–637, 2002. with adenocarcinoma derived from apocrine glands of the anal sac,
590. Grier RL, Brewer WG, Theilen GH: Hyperthermic treatment of Lab Invest 48:428–434, 1983.
superficial tumors in cats and dogs, J Am Vet Med Assoc 177:227– 614. Messinger JS, Windham WR, Ward CR: Ionized hypercalcemia in
233, 1980. dogs: a retrospective study of 109 cases (1998-2003), J Vet Intern
591. Gillette EL: Veterinary radiotherapy, J Am Vet Med Assoc 157:1707– Med 23:514–519, 2009.
1712, 1970. 615. McQuown B, Keyerleber MA, Rosen K, et al.: Treatment of
592. Spugnini EP, Dotsinsky I, Mudrov N, et al.: Biphasic pulses advanced canine anal sac adenocarcinoma with hypofractionated
enhance bleomycin efficacy in a spontaneous canine perianal tumor radiation therapy: 77 cases (1999–2013), Vet Comp Oncol 15:840–
model, J Exp Clin Cancer Res 26:483–487, 2007. 851, 2017.
593. Park C, Yoo JH, Kim HJ, et al.: Cyclosporine treatment of perianal 616. Pradel J, Berlato D, Dobromylskyj M, et al.: Prognostic signifi-
gland adenoma concurrent with benign prostatic hyperplasia in a cance of histopathology in canine anal sac gland adenocarcinomas:
dog, Can Vet J 51:1279–1282, 2010. preliminary results in a retrospective study of 39 cases, Vet Comp
594. Hammer AS, Couto CG, Ayl RD, et al.: Treatment of tumor-bear- Oncol, in press, 2018.
ing dogs with actinomycin D, J Vet Intern Med 8:236–239, 1994. 617. Rosol TJ, Capen CC, Danks JA, et al.: Identification of parathyroid
595. Bley CR, Stankeova S, Sumova A, et al.: Metastases of perianal hormone-related protein in canine apocrine adenocarcinoma of the
gland carcinoma in a dog: palliative tumor therapy, Schweiz Arch anal sac, Vet Pathol 27:89–95, 1990.
Tierheilkd 145:89–94, 2003. 618. Gröne A, Werkmeister JR, Steinmeyer CL, et al.: Parathyroid
596. Simeonov R, Simeonova G: Computer-assisted nuclear morphom- hormone-related protein in normal and neoplastic canine tissues:
etry in the cytological evaluation of canine perianal adenocarcino- immunohistochemical localization and biochemical extraction, Vet
mas, J Comp Path 139:226–230, 2008. Pathol 31:308–315, 1994.
597. Goldschmidt MH, Shofer FS: Skin tumors of the dog and cat, ed 1, 619. Mellanby RJ, Craig R, Evans H, et al.: Plasma concentrations of
Oxford, 1992, Pergamon Press. parathyroid hormone-related protein in dogs with potential disor-
598. Polton GA, Mowat V, Lee HC, et al.: Breed, gender and neuter- ders of calcium metabolism, Vet Rec 159:833–838, 2006.
ing status of British dogs with anal sac gland carcinoma, Vet Comp 620. Hammond TN, Turek MM, Regan J: What is your diagnosis? Met-
Oncol 4:125–131, 2006. astatic anal sac adenocarcinoma with paraneoplastic hypertrophic
599. Bennett PF, DeNicola DB, Bonney P, et al.: Canine anal sac ade- osteopathy, J Am Vet Med Assoc 235:267–268, 2009.
nocarcinomas: clinical presentation and response to therapy, J Vet 621. Giuliano A, Salguero R, Dobson J: Metastatic anal sac carcinoma
Intern Med 16:100–104, 2002. with hypercalcemia and associated hypertrophic osteopathy in a
600. Williams LE, Gliatto JM, Dodge RK, et al.: Carcinoma of the apo- dog, Open Vet J 5:48–51, 2015.
crine glands of the anal sac in dogs: 113 cases (1985-1995), J Am 622. Taylor B, Leibman N, Luong R, et al.: Detection of carcinoma
Vet Med Assoc 223:825–831, 2003. micrometastases in bone marrow of dogs and cats using conven-
601. Polton GA, Brearley MJ: Clinical stage, therapy, and prognosis in tional and cell block cytology, Vet Clin Pathol 42:85–91, 2013.
canine anal sac gland carcinoma, J Vet Intern Med 21:274–280, 2007. 623. Suzuki K, Morita R, Hojo Y, et al.: Immunohistochemical char-
602. Meuten DJ, Cooper BJ, Capen CC, et al.: Hypercalcemia associ- acterization of neuroendocrine differentiation of canine anal sac
ated with an adenocarcinoma derived from the apocrine glands of glandular tumours, J Comp Pathol 149:199–207, 2013.
the anal sac, Vet Pathol 18:454–471, 1981. 624. Polton GA, Brearley MJ, Green LM, et al.: Expression of E-cad-
603. Ross JT, Scavelli TD, Matthiesen DT, et al.: Adenocarcinoma of herin in canine anal sac gland carcinoma and its association with
the apocrine glands of the anal sac in dogs: a review of 32 cases, survival, Vet Comp Oncol 5:232–238, 2007.
J Am Anim Hosp Assoc 27:349–355, 1991. 625. Aguirre-Hernandez J, Polton G, Kennedy LJ, et al.: Associa-
604. Goldschmidt MH, Zoltowski C: Anal sac gland adenocarcinoma in tion between anal sac gland carcinoma and dog leukocyte anti-
the dog: 14 cases, J Small Anim Pract 22:119–128, 1981. gen-DQB1 in the english cocker spaniel, Tissue Antigens 76:
605. Potanas CP, Padgett S, Gamblin RM: Surgical excision of anal 476–481, 2010.
sac apocrine gland adenocarcinomas with and without adjunctive 626. Knudsen CS, Williams A, Brearley MJ, et al.: COX-2 expression in
chemotherapy in dogs: 42 cases (2005–2011), J Am Vet Med Assoc canine anal sac adenocarcinomas and in non-neoplastic canine anal
246:877–884, 2015. sacs, Vet J 197:782–787, 2013.